Utility of Serum CA-125 Monitoring in Patients With Ovarian Cancer Undergoing ICI Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gynecologic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Utility of Serum CA-125 Monitoring in Patients With Ovarian Cancer Undergoing Immune Checkpoint Inhibitor Therapy
Gynecol. Oncol 2020 Jun 02;[EPub Ahead of Print], JL Boland, Q Zhou, AE Iasonos, RE O'Cearbhaill, J Konner, M Callahan, C Friedman, C Aghajanian, P Sabbatini, D Zamarin, KA CadooFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.